Concepts (174)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Papillary | 2 | 2021 | 791 | 0.960 |
Why?
|
| Butanones | 1 | 2021 | 23 | 0.770 |
Why?
|
| 2-Propanol | 1 | 2021 | 28 | 0.760 |
Why?
|
| Thyroid Neoplasms | 5 | 2022 | 2355 | 0.730 |
Why?
|
| Volatile Organic Compounds | 1 | 2021 | 86 | 0.700 |
Why?
|
| Protein Disulfide-Isomerases | 3 | 2021 | 209 | 0.440 |
Why?
|
| Proto-Oncogene Proteins B-raf | 5 | 2019 | 2056 | 0.400 |
Why?
|
| Carcinoma in Situ | 2 | 2021 | 784 | 0.400 |
Why?
|
| Neoplastic Stem Cells | 3 | 2013 | 1349 | 0.350 |
Why?
|
| Mutation | 6 | 2019 | 30214 | 0.310 |
Why?
|
| CpG Islands | 6 | 2009 | 1208 | 0.300 |
Why?
|
| Receptors, Calcitriol | 1 | 2009 | 361 | 0.280 |
Why?
|
| Carcinoma, Pancreatic Ductal | 3 | 2013 | 1757 | 0.280 |
Why?
|
| Colorectal Neoplasms | 9 | 2009 | 6965 | 0.240 |
Why?
|
| ras Proteins | 2 | 2009 | 1055 | 0.240 |
Why?
|
| Thyroid Nodule | 2 | 2022 | 765 | 0.230 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 2 | 2022 | 934 | 0.230 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2022 | 1097 | 0.230 |
Why?
|
| Breast Neoplasms | 5 | 2022 | 21162 | 0.230 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2009 | 2882 | 0.220 |
Why?
|
| Prognosis | 11 | 2021 | 29959 | 0.200 |
Why?
|
| Intermediate Filament Proteins | 2 | 2013 | 261 | 0.190 |
Why?
|
| Down-Regulation | 2 | 2019 | 2931 | 0.190 |
Why?
|
| Parathyroid Neoplasms | 1 | 2022 | 244 | 0.180 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2021 | 355 | 0.180 |
Why?
|
| Pleural Effusion, Malignant | 1 | 2021 | 108 | 0.180 |
Why?
|
| Tracheal Neoplasms | 1 | 2021 | 124 | 0.170 |
Why?
|
| Graves Disease | 1 | 2021 | 239 | 0.170 |
Why?
|
| Neoplasm Staging | 8 | 2021 | 11218 | 0.160 |
Why?
|
| Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing) | 1 | 2018 | 11 | 0.160 |
Why?
|
| Adenocarcinoma | 2 | 2015 | 6359 | 0.150 |
Why?
|
| Neoplasms, Multiple Primary | 2 | 2015 | 594 | 0.150 |
Why?
|
| Pleural Effusion | 1 | 2021 | 344 | 0.150 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 2021 | 262 | 0.150 |
Why?
|
| Japan | 2 | 2019 | 1418 | 0.150 |
Why?
|
| Chromosomal Instability | 2 | 2009 | 176 | 0.150 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2009 | 4523 | 0.150 |
Why?
|
| Deoxyglucose | 1 | 2018 | 322 | 0.140 |
Why?
|
| Carcinoma | 3 | 2019 | 2325 | 0.140 |
Why?
|
| Cysts | 1 | 2022 | 685 | 0.140 |
Why?
|
| Pleural Neoplasms | 1 | 2021 | 584 | 0.140 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2022 | 398 | 0.140 |
Why?
|
| Neoplasm Invasiveness | 3 | 2019 | 3610 | 0.130 |
Why?
|
| Mesothelioma | 1 | 2021 | 774 | 0.130 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2019 | 588 | 0.120 |
Why?
|
| Peutz-Jeghers Syndrome | 1 | 2015 | 61 | 0.120 |
Why?
|
| Neoplasms, Second Primary | 1 | 2022 | 1062 | 0.110 |
Why?
|
| DNA Methylation | 6 | 2009 | 4427 | 0.110 |
Why?
|
| Lymphatic Metastasis | 1 | 2021 | 2901 | 0.110 |
Why?
|
| ROC Curve | 1 | 2021 | 3621 | 0.110 |
Why?
|
| Microsatellite Instability | 4 | 2009 | 726 | 0.110 |
Why?
|
| Colonic Neoplasms | 3 | 2009 | 2535 | 0.100 |
Why?
|
| Pancreatic Neoplasms | 3 | 2018 | 5444 | 0.100 |
Why?
|
| Aryldialkylphosphatase | 1 | 2012 | 64 | 0.100 |
Why?
|
| Follow-Up Studies | 5 | 2021 | 39312 | 0.100 |
Why?
|
| Adenoma | 1 | 2022 | 2155 | 0.100 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 3 | 2009 | 904 | 0.090 |
Why?
|
| Placenta | 1 | 2020 | 1726 | 0.090 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2016 | 616 | 0.090 |
Why?
|
| Aged | 18 | 2022 | 171344 | 0.090 |
Why?
|
| Lymph Nodes | 1 | 2021 | 3468 | 0.090 |
Why?
|
| Genes, bcl-1 | 1 | 2009 | 11 | 0.080 |
Why?
|
| Humans | 35 | 2022 | 766812 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 2 | 2013 | 4401 | 0.080 |
Why?
|
| Female | 26 | 2022 | 396532 | 0.080 |
Why?
|
| Cell Line, Tumor | 5 | 2019 | 17089 | 0.080 |
Why?
|
| Stathmin | 1 | 2009 | 70 | 0.080 |
Why?
|
| Middle Aged | 17 | 2022 | 223267 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2019 | 8623 | 0.080 |
Why?
|
| Carcinoma, Signet Ring Cell | 1 | 2009 | 80 | 0.080 |
Why?
|
| Antigens, Viral, Tumor | 1 | 2009 | 153 | 0.080 |
Why?
|
| Stomach Neoplasms | 1 | 2019 | 1480 | 0.080 |
Why?
|
| Receptors, CXCR4 | 1 | 2012 | 729 | 0.070 |
Why?
|
| Immunohistochemistry | 5 | 2015 | 11062 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2022 | 20146 | 0.070 |
Why?
|
| Case-Control Studies | 3 | 2021 | 22248 | 0.070 |
Why?
|
| Genes, p53 | 1 | 2009 | 711 | 0.070 |
Why?
|
| Cyclooxygenase 2 | 1 | 2008 | 597 | 0.070 |
Why?
|
| Sirtuins | 1 | 2009 | 322 | 0.070 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2019 | 2329 | 0.070 |
Why?
|
| Uterine Neoplasms | 1 | 2015 | 1424 | 0.070 |
Why?
|
| PPAR gamma | 1 | 2008 | 484 | 0.060 |
Why?
|
| Apoptosis | 2 | 2019 | 9514 | 0.060 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2009 | 523 | 0.060 |
Why?
|
| Glycoproteins | 1 | 2012 | 2201 | 0.060 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2009 | 1762 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2009 | 6514 | 0.060 |
Why?
|
| Young Adult | 3 | 2021 | 59939 | 0.060 |
Why?
|
| Aged, 80 and over | 4 | 2022 | 59548 | 0.050 |
Why?
|
| Male | 19 | 2021 | 364154 | 0.050 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2019 | 4050 | 0.050 |
Why?
|
| Adult | 7 | 2022 | 223305 | 0.050 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 3600 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 4356 | 0.050 |
Why?
|
| Age Factors | 1 | 2019 | 18397 | 0.050 |
Why?
|
| Adolescent | 2 | 2021 | 88902 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2012 | 4033 | 0.050 |
Why?
|
| Incidence | 1 | 2019 | 21527 | 0.050 |
Why?
|
| Endoscopes | 1 | 2022 | 169 | 0.050 |
Why?
|
| Cohort Studies | 8 | 2009 | 41706 | 0.050 |
Why?
|
| Peptides | 1 | 2012 | 4347 | 0.040 |
Why?
|
| Punctures | 1 | 2021 | 371 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2009 | 6329 | 0.040 |
Why?
|
| Radioisotopes | 1 | 2021 | 509 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 2019 | 5860 | 0.040 |
Why?
|
| Multivariate Analysis | 2 | 2009 | 12064 | 0.040 |
Why?
|
| Microarray Analysis | 1 | 2021 | 751 | 0.040 |
Why?
|
| Autopsy | 1 | 2021 | 1011 | 0.040 |
Why?
|
| Neck | 1 | 2022 | 736 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2019 | 8310 | 0.040 |
Why?
|
| Long Interspersed Nucleotide Elements | 2 | 2009 | 332 | 0.040 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2020 | 468 | 0.040 |
Why?
|
| Fetal Growth Retardation | 1 | 2020 | 591 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2022 | 81657 | 0.030 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2021 | 1131 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2019 | 23618 | 0.030 |
Why?
|
| Amino Acids | 1 | 2022 | 1711 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2021 | 2510 | 0.030 |
Why?
|
| Glycosylation | 1 | 2018 | 1099 | 0.030 |
Why?
|
| Trachea | 1 | 2021 | 1094 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2019 | 872 | 0.030 |
Why?
|
| Cell Dedifferentiation | 1 | 2015 | 125 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 1604 | 0.030 |
Why?
|
| Phenotype | 2 | 2009 | 16722 | 0.030 |
Why?
|
| Neoplasms | 1 | 2022 | 22350 | 0.030 |
Why?
|
| Prospective Studies | 4 | 2009 | 54872 | 0.030 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2019 | 1362 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2019 | 10101 | 0.020 |
Why?
|
| RNA | 1 | 2022 | 2715 | 0.020 |
Why?
|
| Endoscopy | 1 | 2022 | 1854 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2015 | 705 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2009 | 13050 | 0.020 |
Why?
|
| Pancreas | 1 | 2018 | 1698 | 0.020 |
Why?
|
| Survival Rate | 3 | 2009 | 12826 | 0.020 |
Why?
|
| Mammography | 1 | 2021 | 2429 | 0.020 |
Why?
|
| Hysterectomy | 1 | 2015 | 863 | 0.020 |
Why?
|
| DNA-Cytosine Methylases | 1 | 2009 | 17 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2022 | 5990 | 0.020 |
Why?
|
| JC Virus | 1 | 2009 | 87 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2022 | 3530 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2009 | 2952 | 0.020 |
Why?
|
| Sirtuin 1 | 1 | 2009 | 247 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2022 | 3235 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2020 | 3582 | 0.020 |
Why?
|
| Cell Movement | 1 | 2019 | 5204 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2009 | 663 | 0.020 |
Why?
|
| Genes, ras | 1 | 2009 | 656 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2015 | 4143 | 0.020 |
Why?
|
| Proteomics | 1 | 2018 | 3915 | 0.010 |
Why?
|
| beta Catenin | 1 | 2009 | 1048 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 2009 | 1741 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2009 | 2342 | 0.010 |
Why?
|
| Biopsy | 1 | 2015 | 6779 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2019 | 10451 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2009 | 1505 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 4570 | 0.010 |
Why?
|
| Disease Progression | 1 | 2019 | 13642 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2012 | 4892 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2019 | 11657 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 6066 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2020 | 26387 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2008 | 2694 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 15425 | 0.010 |
Why?
|
| Pregnancy | 1 | 2020 | 30236 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2009 | 4780 | 0.010 |
Why?
|
| Infant | 1 | 2020 | 36459 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2009 | 5795 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 2008 | 3041 | 0.010 |
Why?
|
| Logistic Models | 1 | 2009 | 13276 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2008 | 12536 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2009 | 8065 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2009 | 9528 | 0.010 |
Why?
|
| Models, Biological | 1 | 2009 | 9464 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 36570 | 0.000 |
Why?
|
Concepts
(174)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(23)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_